Pilot study on developing a decision support tool for guiding re-administration of chemotherapeutic agent after a serious adverse drug reaction

BACKGROUND: Currently, there are no standard guidelines for recommending re-administration of a chemotherapeutic drug to a patient after a serious adverse drug reaction (ADR) incident. The decision on whether to rechallenge the patient is based on the experience of the clinician and is highly subjec...

Descripción completa

Detalles Bibliográficos
Autores principales: Loke, Pei Yi, Chew, Lita, Yap, Chun Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161037/
https://www.ncbi.nlm.nih.gov/pubmed/21794175
http://dx.doi.org/10.1186/1471-2407-11-319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161037/
https://www.ncbi.nlm.nih.gov/pubmed/21794175
http://dx.doi.org/10.1186/1471-2407-11-319

Ejemplares similares